Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check25 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check39 days agoChange DetectedThe date has been updated from May 4, 2025, to May 9, 2025.SummaryDifference0.3%
- Check47 days agoChange DetectedThe date for an event has been updated from April 20, 2025, to May 4, 2025.SummaryDifference0.3%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.